121 related articles for article (PubMed ID: 3261884)
1. Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.
Preijers FW; De Witte T; Rijke-Schilder GP; Tax WJ; Wessels JM; Haanen C; Capel PJ
Scand J Immunol; 1988 Aug; 28(2):185-94. PubMed ID: 3261884
[TBL] [Abstract][Full Text] [Related]
2. Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins.
Preijers FW; Tax WJ; De Witte T; Janssen A; vd Heijden H; Vidal H; Wessels JM; Capel PJ
Br J Haematol; 1988 Nov; 70(3):289-94. PubMed ID: 3264717
[TBL] [Abstract][Full Text] [Related]
3. Different susceptibilities of normal T cells and T cell lines to immunotoxins.
Preijers FW; Tax WJ; Wessels JM; Capel PJ; De Witte T; Haanen C
Scand J Immunol; 1988 May; 27(5):533-40. PubMed ID: 3259720
[TBL] [Abstract][Full Text] [Related]
4. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
5. Cell-type-specific cytotoxicity of anti-CD4 and anti-CD8 ricin immunotoxins against human alloreactive T-cell clones.
Uckun FM; Myers DE; Ledbetter JA; Wee SL; Vallera DA
Blood; 1989 Nov; 74(7):2445-54. PubMed ID: 2572287
[TBL] [Abstract][Full Text] [Related]
6. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
Preijers FW; De Witte T; Wessels JM; De Gast GC; Van Leeuwen E; Capel PJ; Haanen C
Blood; 1989 Aug; 74(3):1152-8. PubMed ID: 2473811
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ
Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323
[TBL] [Abstract][Full Text] [Related]
9. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
10. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
11. Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.
Izquierdo M; Balboa MA; Figuera A; López-Botet M
Clin Exp Immunol; 1988 Nov; 74(2):300-4. PubMed ID: 3265657
[TBL] [Abstract][Full Text] [Related]
12. A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.
van Oosterhout YV; van Emst L; Schattenberg AV; Tax WJ; Ruiter DJ; Spits H; Nagengast FM; Masereeuw R; Evers S; de Witte T; Preijers FW
Blood; 2000 Jun; 95(12):3693-701. PubMed ID: 10845899
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD2 (T, p50) intact ricin immunotoxins for GVHD-prophylaxis in allogeneic bone marrow transplantation.
Uckun FM; Azemove SM; Myers DE; Vallera DA
Leuk Res; 1986; 10(2):145-53. PubMed ID: 3512922
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
Xu M; Lu S; Shen B; Li Y
Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
[TBL] [Abstract][Full Text] [Related]
15. Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins.
Katz FE; Janossy G; Cumber A; Ross W; Blacklock HA; Tax W; Thorpe PE
Br J Haematol; 1987 Dec; 67(4):407-11. PubMed ID: 3501311
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes.
Vinci G; Vernant JP; Nakazawa M; Zohair M; Katz A; Henri A; Rochant H; Breton-Gorius J; Vainchenker W
Blood; 1988 Nov; 72(5):1616-21. PubMed ID: 2972326
[TBL] [Abstract][Full Text] [Related]
18. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bregni M; Bonnadonna G; Gianni AM
Blood; 1987 Jan; 69(1):345-8. PubMed ID: 3098324
[TBL] [Abstract][Full Text] [Related]
19. Antigenic modulation induced by four monoclonal antibodies adsorbed on gold particles (specificity anti-CD4, anti-CD5, anti-CD7, and anti-150-kDa antigen): relationship between modulation and cytotoxic activity of immunotoxins.
Carriere D; Arcier JM; Derocq JM; Fontaine C; Richer G
Exp Cell Res; 1989 May; 182(1):114-28. PubMed ID: 2785456
[TBL] [Abstract][Full Text] [Related]
20. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
Stong RC; Uckun F; Youle RJ; Kersey JH; Vallera DA
Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
